Value through Innovation27 July 2016

Clinical Study Results

  • BI 695500 - Lymphoma, Follicular
    Clinical Study Number 1301.5
    Study Indication Lymphoma, Follicular
    Product BI 695500
    Generic Name BI 695500
    Lab Code BI 695500
    Clinical Phase I
    Study Title

    A randomized, double-blind, parallel-arm, Phase I study to evaluate pharmacokinetics and pharmacodynamics of BI 695500 vs. rituximab (MabThera®) induction immunotherapy as firstline treatment in patients with low tumor burden follicular lymphoma.

    Study Document Trial synopsis 1301.5 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.